The FDA analyzed data from its Adverse Event Reporting System and included 25 drugs or drug classes in its quarterly update of medications that have a potential for serious risk or have new safety information. The list, current as of Oct. 5, includes 12 drugs in the category of glucagon-like peptide 1 receptor agonists for type 2 diabetes.
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.